End of CRISPR-CAS9 controversy
Tuesday, February 10, 2015 - 09:00
in Biology & Nature
The IBS research team (Center for Genome Engineering) has successfully confirmed that CRISPR-Cas9 has accurate on-target effects in human cells, through joint research with the Seoul National University College of Medicine and ToolGen, Inc.